Deferred Income Tax Liabilities, Net of Passage BIO, Inc. from 31 Dec 2021 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary: Passage BIO, Inc. quarterly Deferred Income Tax Liabilities, Net in USD history and change rate from 31 Dec 2021 to 31 Dec 2024.
Passage BIO, Inc. Deferred Income Tax Liabilities, Net for the quarter ending 31 Dec 2024 was $4,445,000, a 24% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Income Tax Liabilities, Net, Quarterly (USD)

Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

Passage BIO, Inc. Quarterly Deferred Income Tax Liabilities, Net (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$4,445,000	-$1,387,000	-24%	31 Dec 2024	10-K	04 Mar 2025	2024	FY
Q4 2023	$5,832,000	-$2,590,000	-31%	31 Dec 2023	10-K	04 Mar 2025	2024	FY
Q4 2022	$8,422,000	+$7,199,000	+589%	31 Dec 2022	10-K	04 Mar 2024	2023	FY
Q4 2021	$1,223,000			31 Dec 2021	10-K	06 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.